20571524|t|Intact memory in TGF-beta1 transgenic mice featuring chronic cerebrovascular deficit: recovery with pioglitazone.
20571524|a|The roles of chronic brain hypoperfusion and transforming growth factor-beta 1 (TGF-beta1) in Alzheimer's disease (AD) are unresolved. We investigated the interplay between TGF-beta1, cerebrovascular function, and cognition using transgenic TGF mice featuring astrocytic TGF-beta1 overexpression. We further assessed the impact of short, late therapy in elderly animals with the antioxidant N-acetyl-L-cysteine (NAC) or the peroxisome proliferator-activated receptor-gamma agonist pioglitazone. The latter was also administered to pups as a prophylactic 1-year treatment. Elderly TGF mice featured cerebrovascular dysfunction that was not remedied with NAC. In contrast, pioglitazone prevented or reversed this deficit, and rescued the impaired neurovascular coupling response to whisker stimulation, although it failed to normalize the vascular structure. In aged TGF mice, neuronal and cognitive indices--the stimulus-evoked neurometabolic response, cortical cholinergic innervation, and spatial memory in the Morris water maze--were intact. Our findings show that impaired brain hemodynamics and cerebrovascular function are not accompanied by memory impairment in this model. Conceivably in AD, they constitute aggravating factors against a background of aging and underlying pathology. Our data further highlight the ability of pioglitazone to protect the cerebrovasculature marked by TGF-beta1 increase, aging, fibrosis, and antioxidant resistance, thus of high relevance for AD patients.
20571524	17	26	TGF-beta1	Gene	21803
20571524	38	42	mice	Species	10090
20571524	61	84	cerebrovascular deficit	Disease	MESH:D002561
20571524	100	112	pioglitazone	Chemical	MESH:D000077205
20571524	135	154	brain hypoperfusion	Disease	MESH:D001927
20571524	159	192	transforming growth factor-beta 1	Gene	21803
20571524	194	203	TGF-beta1	Gene	21803
20571524	208	227	Alzheimer's disease	Disease	MESH:D000544
20571524	229	231	AD	Disease	MESH:D000544
20571524	287	296	TGF-beta1	Gene	21803
20571524	359	363	mice	Species	10090
20571524	385	394	TGF-beta1	Gene	21803
20571524	505	524	N-acetyl-L-cysteine	Chemical	MESH:D000111
20571524	526	529	NAC	Chemical	MESH:D000111
20571524	538	586	peroxisome proliferator-activated receptor-gamma	Gene	19016
20571524	595	607	pioglitazone	Chemical	MESH:D000077205
20571524	698	702	mice	Species	10090
20571524	712	739	cerebrovascular dysfunction	Disease	MESH:D002561
20571524	767	770	NAC	Chemical	MESH:D000111
20571524	785	797	pioglitazone	Chemical	MESH:D000077205
20571524	983	987	mice	Species	10090
20571524	1196	1208	hemodynamics	Disease	
20571524	1261	1278	memory impairment	Disease	MESH:D008569
20571524	1309	1311	AD	Disease	MESH:D000544
20571524	1447	1459	pioglitazone	Chemical	MESH:D000077205
20571524	1504	1513	TGF-beta1	Gene	21803
20571524	1531	1539	fibrosis	Disease	MESH:D005355
20571524	1596	1598	AD	Disease	MESH:D000544
20571524	1599	1607	patients	Species	9606
20571524	Association	MESH:D000544	21803
20571524	Negative_Correlation	MESH:D000077205	MESH:D000544
20571524	Negative_Correlation	MESH:D000077205	MESH:D002561
20571524	Negative_Correlation	MESH:D000077205	21803
20571524	Positive_Correlation	MESH:D000077205	19016
20571524	Association	MESH:D002561	21803
20571524	Negative_Correlation	MESH:D000077205	MESH:D005355

